- Home
- PULM vs SWIN Comparison
PULM vs SWIN Comparison
Compare PULM & SWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- SWIN
- Stock Information
- Founded
- PULM 2003
- SWIN 2017
- Country
- PULM United States
- SWIN Hong Kong
- Employees
- PULM N/A
- SWIN N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- SWIN
- Sector
- PULM Health Care
- SWIN
- Exchange
- PULM Nasdaq
- SWIN Nasdaq
- Market Cap
- PULM 33.2M
- SWIN 32.1M
- IPO Year
- PULM N/A
- SWIN 2023
- Fundamental
- Price
- PULM $6.38
- SWIN $3.29
- Analyst Decision
- PULM
- SWIN
- Analyst Count
- PULM 0
- SWIN 0
- Target Price
- PULM N/A
- SWIN N/A
- AVG Volume (30 Days)
- PULM 60.0K
- SWIN 272.7K
- Earning Date
- PULM 08-12-2025
- SWIN 08-21-2025
- Dividend Yield
- PULM N/A
- SWIN N/A
- EPS Growth
- PULM N/A
- SWIN N/A
- EPS
- PULM N/A
- SWIN N/A
- Revenue
- PULM $1,921,000.00
- SWIN $3,316,000.00
- Revenue This Year
- PULM N/A
- SWIN $29.79
- Revenue Next Year
- PULM $134.88
- SWIN $54.60
- P/E Ratio
- PULM N/A
- SWIN N/A
- Revenue Growth
- PULM N/A
- SWIN N/A
- 52 Week Low
- PULM $1.78
- SWIN $1.16
- 52 Week High
- PULM $10.40
- SWIN $4.40
- Technical
- Relative Strength Index (RSI)
- PULM 39.53
- SWIN 58.50
- Support Level
- PULM $6.26
- SWIN $2.88
- Resistance Level
- PULM $6.96
- SWIN $4.40
- Average True Range (ATR)
- PULM 0.85
- SWIN 0.48
- MACD
- PULM -0.11
- SWIN 0.01
- Stochastic Oscillator
- PULM 39.71
- SWIN 47.14
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About SWIN Solowin Holdings
Solowin Holdings Ltd is a investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secured one-stop electronic platform. It is engaged in providing securities related services, investment advisory service, and asset management service to customers. The operations were organized into four reportable segments: securities related services, investment advisory services, corporate consultancy services, and asset management services. It derives maximum revenue from investment advisory services.